We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Italian Firm Acquires Fast Melt Technology

By Biotechdaily staff writers
Posted on 07 Feb 2003
The worldwide rights to a new pharmaceutical fast melt technology and manufacturing process have been acquired by Eurand (Milan, Italy) under an agreement with Kyowa Hakko Kogyo Co., Ltd. More...
(Tokyo, Japan).

The new fast melt technology will allow patients to take their medications anytime, anywhere without chewing or the need for water. The technology produces an orally administered fast-dissolving dosage form and is broadly applicable, since it can be used with both soluble and insoluble products. The tablet is produced using a proprietary system that utilizes 10-30 times less hydrophobic lubricant than conventional tablet production. The resulting tablet is both hard and durable but does not impede liquid entry upon contact with saliva. In addition, the tablet does not contain water-insensitive cohesive bonds between particles to hinder disintegration. Eurand intends to market the products in combination with Microcaps, the company's taste-masking technology.

"This technology is different from the competition in that while it offers a first class fast melt tablet in terms of speed of disintegration, it is both easy to produce and more robust than other fast melt tablets,” noted Gearoid Faherty, CEO of Eurand.





Related Links:
Eurand
Kyowa

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automatic CLIA Analyzer
Shine i6000
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.